The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback